Currently I am associated with Longevity Tech Fund as the group CSO since Dec 2021 PhD in Biotechnology (2001). Multinational experience in big pharma-based drug discovery, including C-level management positions in several companies in regenerative medicine, cell therapy and longevity. Also worked extensively as a consultant and in academia (professor at a medical university). Investment experience including an Oxford diploma and tech diligence for angel investors and philanthropists, leading to joining PML in April 2021.
